Veronique Barry

Subscribe to all posts by Veronique Barry

Quebec maintains drug evaluation activities for listing purposes and launches clinical trials

By Fortunat Nadima Nadima, Veronique Barry and Olga Farman on April 13, 2020 Posted in Life sciences and healthcare, Pharmaceuticals and life sciences

In this post, the Pharma in Brief team reports on two recent developments in the Quebec regulatory landscape related to the COVID-19 crisis. Adjustments to submission procedure for applications for listing of innovative drugs and blood products on formulary On April 6, 2020, Quebec’s Institut national d’excellence en santé et en services sociaux (INESSS) issued … Continue reading

Health Canada consulting on draft guidance distinguishing promotional and non-promotional activities for health products

By Meghan Allard and Veronique Barry on July 22, 2019 Posted in Life sciences and healthcare, Pharmaceuticals and life sciences

Health Canada is consulting on a draft guidance document entitled The Distinction Between Promotional and Non-promotional Messages and Activities for Health Products (Draft Guidance), which is intended to replace the current 1996 policy entitled The Distinction Between Advertising and Other Activities (Current Policy). Copies of the Draft Guidance are available from Health Canada on request; … Continue reading

Bill 148 : A Bill to limit generic medication procurement by owner pharmacists

By Veronique Barry and Gregory Bordan on November 7, 2017 Posted in Pharmaceuticals and life sciences

Bill 148, An Act to regulate generic medication procurement by owner pharmacists and to amend various legislative provisions, was tabled in the National Assembly on October 5. It will amend An Act respecting Prescription Drug Insurance, introducing the Regulation to govern generic medication procurement by owner pharmacists. The new Regulation will provide, subject to certain exceptions, … Continue reading